Toward pharmacogenetic SLCO1B1‐guided dosing of methotrexate in arthritis using a murine Slco1b2 knockout model

• Päätekijät: Zachary L. Taylor (Tekijä), Lauren E. Thompson (Tekijä), Heather Bear (Tekijä), Tomoyuki Mizuno (Tekijä), Alexander A. Vinks (Tekijä), Laura B. Ramsey (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Wiley, 2021-11-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Abstract Low‐dose methotrexate (MTX) is a first‐line therapy for the treatment of arthritis. However, there is considerable interindividual variability in MTX exposure following standard dosing. Polymorphisms in SLCO1B1 significantly effect MTX clearance, altering therapeutic response. One decreased...